• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Americas Insomnia Companies

    ID: MRFR/Pharma/0126-HCR
    50 Pages
    Rahul Gotadki
    September 2025

    America's Insomnia Companies is a pioneering conglomerate dedicated to addressing the growing global concern of sleep disorders. With a commitment to advancing sleep science, our subsidiaries focus on cutting-edge research, innovative therapies, and state-of-the-art sleep solutions.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Americas Insomnia Market

    Americas Insomnia Key Companies

     

    Latest Americas Insomnia Companies Update


    Eisai Co. Acquired the manufacturing rights and intellectual property for API to develop a new insomnia treatment, INVEGA SUSTENNA, currently in Phase III clinical trials.


    Purdue Pharma L.P Faced ongoing legal challenges related to OxyContin and other opioid painkillers, impacting their sleep medication portfolio like Stadol NS.


    Calm Leading meditation and sleep app platform, achieved unicorn status with a $4 billion valuation, highlighting the growing popularity of digital sleep solutions.


    Headspace Another popular sleep and mindfulness app, partnered with several healthcare providers to integrate their platform into treatment plans.


    List of Americas Insomnia Key Companies in the Market



    • Eisai Co. (Japan)

    • Pfizer Inc. (US)

    • Merck & Co Inc (US)

    • Sanofi (France)

    • Takeda Pharmaceutical Company (Japan)

    • Meda Consumer Healthcare Inc (US)

    • Pernix Therapeutics (US)

    • Purdue Pharma L.P. (US)

    • Consumer Healthcare Inc. (Canada)

    • Dainippon Sumitomo (Japan)

    • ECR Pharmaceuticals (US)

    • Flynn Pharma (UK)

    • Johnson & Johnson (US)

    • Astellas (UK)

    • Biocodex S A (France)

    • Neurim (Switzerland)

    • SkyePharma (UK)

    • Vanda Pharmaceuticals Inc. (US).